{ "company_number": "04843395", "name": "Walpole Pharmaceuticals Limited", "url": "/company/04843395", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2003-07-23", "dissolved_on": null, "sic_codes": [ "47730" ], "registered_address": { "id": 2206076, "url": "/address/2206076", "line1": "43 OVERSTONE ROAD", "line2": "", "post_town": "LONDON", "county": "", "country": "", "postcode": "W6 0AD" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395", "previous_names": [], "care_of": "MICHAEL LEONG AND COMPANY", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/04843395/accounts/2025-03-31", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "1101.00", "debtors": "220619.00", "cash_bank_in_hand": "30644.00", "current_assets": "343246.00", "creditors_due_within_one_year": "226071.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "117175.00", "total_assets_less_current_liabilities": "118276.00", "net_assets_liabilities": "118276.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "118176.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2025.zip" }, { "url": "/company/04843395/accounts/2024-03-31", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "597.00", "debtors": "179358.00", "cash_bank_in_hand": "20470.00", "current_assets": "302989.00", "creditors_due_within_one_year": "225920.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "77069.00", "total_assets_less_current_liabilities": "77666.00", "net_assets_liabilities": "77666.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "77566.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/04843395/accounts/2023-03-31", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "833.00", "debtors": "179857.00", "cash_bank_in_hand": "40684.00", "current_assets": "326619.00", "creditors_due_within_one_year": "212541.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "114078.00", "total_assets_less_current_liabilities": "114911.00", "net_assets_liabilities": "114911.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "114811.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2023.zip" }, { "url": "/company/04843395/accounts/2022-03-31", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "1925.00", "debtors": "193009.00", "cash_bank_in_hand": "102161.00", "current_assets": "402788.00", "creditors_due_within_one_year": "214368.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "188420.00", "total_assets_less_current_liabilities": "190345.00", "net_assets_liabilities": "190345.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "190245.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2022.zip" }, { "url": "/company/04843395/accounts/2021-03-31", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "1215.00", "debtors": "258344.00", "cash_bank_in_hand": "65591.00", "current_assets": "435670.00", "creditors_due_within_one_year": "241981.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "193689.00", "total_assets_less_current_liabilities": "194904.00", "net_assets_liabilities": "194904.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "194804.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2021.zip" }, { "url": "/company/04843395/accounts/2020-03-31", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": "5.00", "tangible_fixed_assets": "935.00", "debtors": "240873.00", "cash_bank_in_hand": "38658.00", "current_assets": "383345.00", "creditors_due_within_one_year": "235253.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "148092.00", "total_assets_less_current_liabilities": "149027.00", "net_assets_liabilities": "149027.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "148927.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2020.zip" }, { "url": "/company/04843395/accounts/2019-03-31", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "198649.00", "cash_bank_in_hand": "104101.00", "current_assets": "406690.00", "creditors_due_within_one_year": "198245.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "208445.00", "total_assets_less_current_liabilities": "208445.00", "net_assets_liabilities": "208445.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "208345.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2019.zip" }, { "url": "/company/04843395/accounts/2018-03-31", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1066.00", "debtors": "298570.00", "cash_bank_in_hand": "16121.00", "current_assets": "418380.00", "creditors_due_within_one_year": "204455.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "213925.00", "total_assets_less_current_liabilities": "214991.00", "net_assets_liabilities": "214991.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "214891.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2018.zip" }, { "url": "/company/04843395/accounts/2016-03-31", "made_up_date": "2016-03-31", "period_start": "2016-03-31", "period_end": "2016-03-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "225.00", "debtors": "215057.00", "cash_bank_in_hand": "87035.00", "current_assets": "416347.00", "creditors_due_within_one_year": "229506.00", "creditors_due_after_one_year": "20545.00", "net_current_assets_liabilities": "186841.00", "total_assets_less_current_liabilities": "187066.00", "net_assets_liabilities": "166521.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "166421.00", "shareholder_funds": "166521.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2016.zip" }, { "url": "/company/04843395/accounts/2014-07-31", "made_up_date": "2014-07-31", "period_start": "2014-07-31", "period_end": "2014-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "977.00", "debtors": "229567.00", "cash_bank_in_hand": "141843.00", "current_assets": "434618.00", "creditors_due_within_one_year": "238874.00", "creditors_due_after_one_year": "36665.00", "net_current_assets_liabilities": "195744.00", "total_assets_less_current_liabilities": "196721.00", "net_assets_liabilities": "160056.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "159956.00", "shareholder_funds": "160056.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2015.zip" }, { "url": "/company/04843395/accounts/2013-07-31", "made_up_date": "2013-07-31", "period_start": "2013-07-31", "period_end": "2013-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "334.00", "debtors": "216627.00", "cash_bank_in_hand": "107878.00", "current_assets": "372005.00", "creditors_due_within_one_year": "229566.00", "creditors_due_after_one_year": "49645.00", "net_current_assets_liabilities": "142439.00", "total_assets_less_current_liabilities": "142773.00", "net_assets_liabilities": "93128.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "93028.00", "shareholder_funds": "93128.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2014.zip" }, { "url": "/company/04843395/accounts/2012-07-31", "made_up_date": "2012-07-31", "period_start": "2012-07-31", "period_end": "2012-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "75157.00", "debtors": "218304.00", "cash_bank_in_hand": "94253.00", "current_assets": "357857.00", "creditors_due_within_one_year": "224393.00", "creditors_due_after_one_year": "92102.00", "net_current_assets_liabilities": "133464.00", "total_assets_less_current_liabilities": "208621.00", "net_assets_liabilities": "116519.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "116419.00", "shareholder_funds": "116519.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2013.zip" }, { "url": "/company/04843395/accounts/2011-07-31", "made_up_date": "2011-07-31", "period_start": "2011-07-31", "period_end": "2011-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "150303.00", "debtors": "217651.00", "cash_bank_in_hand": "1.00", "current_assets": "253120.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "21036.00", "total_assets_less_current_liabilities": "171339.00", "net_assets_liabilities": "38217.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "38117.00", "shareholder_funds": "38217.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2012.zip" }, { "url": "/company/04843395/accounts/2010-07-31", "made_up_date": "2010-07-31", "period_start": "2010-07-31", "period_end": "2010-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "238342.00", "debtors": "156320.00", "cash_bank_in_hand": "129089.00", "current_assets": "325695.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "16336.00", "total_assets_less_current_liabilities": "254678.00", "net_assets_liabilities": "125422.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "125322.00", "shareholder_funds": "125422.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2011.zip" }, { "url": "/company/04843395/accounts/2009-07-31", "made_up_date": "2009-07-31", "period_start": "2009-07-31", "period_end": "2009-07-31", "entity_name": "Walpole Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "332786.00", "debtors": "142281.00", "cash_bank_in_hand": "97679.00", "current_assets": "302154.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-32165.00", "total_assets_less_current_liabilities": "300621.00", "net_assets_liabilities": "113711.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "113611.00", "shareholder_funds": "113711.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2010.zip" } ], "pdf_only_filings": [ { "made_up_date": "2017-03-31", "filing_date": "2017-11-21", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-full", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2017-03-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MzE5MDQ1NTIxMWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2015-03-31", "filing_date": "2015-08-20", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2015-03-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MzEyOTA3NjM5OWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2008-07-31", "filing_date": "2009-03-23", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2008-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MjAyODczMjQ1M2FkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2007-07-31", "filing_date": "2008-05-30", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2007-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MjAwNjM0NjcyOGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2006-07-31", "filing_date": "2007-05-30", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": null, "pdf_url": "/company/04843395/accounts/2006-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MTgwODE3NDM5YWRpcXprY3g/document?format=pdf&download=0" }, { "made_up_date": "2005-07-31", "filing_date": "2006-05-31", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2005-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/MTYwNzU3MzQ4YWRpcXprY3g/document?format=pdf&download=0" }, { "made_up_date": "2004-07-31", "filing_date": "2005-05-23", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-small", "paper_filed": true, "pdf_url": "/company/04843395/accounts/2004-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history/Nzg0OTMyMDVhZGlxemtjeA/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/04843395/filing-history" }, "confirmation_statement": { "next_due": "2026-08-06", "last_made_up": "2025-07-23" }, "officers": [], "psc": [ { "name": "Mrs Susan Elizabeth Ubbi", "kind": "individual-person-with-significant-control", "person_url": "/person/4883550", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2016-04-07", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-07-01", "retrieved_at": "2026-07-26T04:18:29.780769+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }